CureGN Observational Study
at Columbia University

CureGN is an NIH-sponsored observational study on glomerular diseases which will include 600 patients with membranous nephropathy. The goals of this study are to advance the science behind our understanding of these diseases We hope to answer some of the most common questions patients have for their nephrologists:

• What is this disease?
• Why do I have this disease?
• What will happen to me?
• What effective treatments can you offer me?

Patients with recently diagnosed membranous nephropathy (a biopsy within the past 5 years) are eligible to participate in this important study. They will be asked to come to a study center once or twice a year, contribute blood and urine specimens for banking in a national biorepository, and answer questionnaires about their disease course.